Mark Wilcox
Direktor/Vorstandsmitglied bei Phico Therapeutics Ltd.
Aktive Positionen von Mark Wilcox
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Phico Therapeutics Ltd.
 Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 15.01.2019 | - |
Karriereverlauf von Mark Wilcox
Statistik
International
| Vereinigtes Königreich | 2 |
Operativ
| Director/Board Member | 1 |
Sektoral
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Phico Therapeutics Ltd. develops antibiotic bacteria resistant technology. Its products include SASPject PT1.2 used for intra-nasal decolonization, SASPject PT3.1 used for intra-abdominal infections and SASPject PT4 used for both the infections. The company was founded by Dr. Heather Fairhead and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Börse
- Insiders
- Mark Wilcox
- Erfahrung
